|Articles|June 1, 1999

June 1999
Volume 5
Issue 6

The Impact of TennCare on Patient Satisfaction with Care

Author(s)Christopher J. Conover, PhD, May Ling Mah, BS, Peter J. Rankin, MA

Articles in this issue

over 26 years ago

Article

Variations in and Correlates of Length of Stay in Academic Hospitals among Patients with Heart Failure Resulting from Systolic Dysfunction

over 26 years ago

Article

Continuity of Care: Is It Cost Effective?

over 26 years ago

Article

Nursing Facilities and Managed Care

over 26 years ago

Article

The Role of Respiratory Care Practitioners in a Changing Healthcare System: Emerging Areas of Clinical Practice

over 26 years ago

Article

Continuation of Postmenopausal Hormone Replacement Therapy in a Large Health Maintenance Organization: Transdermal Matrix Patch versus Oral Estrogen Therapy

over 26 years ago

Article

Topical Corticosteroids: Considerations for Appropriate Use

over 26 years ago

Article

Variation in Length of Stay in Patients Hospitalized with Congestive Heart Failure

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Cost-Effectiveness Analysis of Ubrogepant, Rimegepant, and Zavegepant for Acute Migraine Treatment vs Usual Care

ByPooja Gokhale, PharmD,Lorenzo Villa Zapata, PhD

November 18th 2025

Evaluating Racial Concordance in a Telephonic Care Management Program Among Black Patients

ByMelanie Canterberry, PhD,Aina Katsikas, PhD,Amanda K. Sutherland, PhD,Yong Li, PhD,Emily Boudreau, PhD,Brian W. Powers, MD, MBA

November 17th 2025

Insurance-Related Differences in Chronic Conditions Data Warehouse Comorbidities of Medicare Beneficiaries

ByJustin M. Schaffer, MD,John J. Squiers, MD,Austin Kluis, MD,Jasjit K. Banwait, PhD,Mario F. L. Gaudino, MD, PhD,Michael J. Mack, MD,J. Michael DiMaio, MD

November 14th 2025

US Spending on High-Revenue Rare Disease Drugs in 2022

ByHelen Mooney, MPH,Aaron S. Kesselheim, MD, JD, MPH,Benjamin N. Rome, MD, MPH

November 14th 2025

Clinical Setting of Initial Psychotic Spectrum Disorder Diagnoses in an Integrated Health System

ByChristyn Haigler, MD,Andrea H. Kline-Simon, MS,Matthew E. Hirschtritt, MD, MPH,Icelini Stavers-Sosa, MD

November 14th 2025

The Impact of TennCare on Patient Satisfaction with Care

Articles in this issue

Newsletter

Related Content

Cost-Effectiveness Analysis of Ubrogepant, Rimegepant, and Zavegepant for Acute Migraine Treatment vs Usual Care

Evaluating Racial Concordance in a Telephonic Care Management Program Among Black Patients

Insurance-Related Differences in Chronic Conditions Data Warehouse Comorbidities of Medicare Beneficiaries

US Spending on High-Revenue Rare Disease Drugs in 2022

Clinical Setting of Initial Psychotic Spectrum Disorder Diagnoses in an Integrated Health System

Trending on AJMC

Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS

Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL

Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer

The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD

Faricimab Brought Early Control of Some Symptoms in AMD